




|
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
|
||

WIKI ANALYSIS
|
Eclipsys Corporation (NASDAQ:ECLP) makes proprietary software for the pharmaceutical and healthcare industry used for clinical, financial, and operational management.[1] With an operating revenue of $515.76 million in 2008, Eclipsys Corp. is the third largest company by revenue in the Healthcare Information Services industry[2]. Eclipsys's software is used to manage medical records databases directly, and also integrates with electronic systems from competitors such as Cerner (CERN) or Allscripts Healthcare Solutions (MDRX).[3][1] Software sales and support comprised of 96.10% of Eclipsys Corp's revenue in 2008. [4]
Since 2005, the percentage of hospitals primarily relying on electronic medical records systems has increased by 18.4% to 28.4%, or 1620 of the roughly 5,700 hospitals in 2008.[5][6] Ease of use and lower costs have fueled this growth of the IT-based healthcare industry, and increases in healthcare spending, safety and quality concerns, and healthcare deficiets have created a favorable environment for its expansion.[7] Industry growth drove Eclipsys Corp's 10.42% year-over-year growth on average since 2005.[8]
The development of IT-based healthcare management has been international, but Eclipsys's global expansion efforts have encountered limited success.[7] The company operates in highly competitive markets with companies that have greater financial and technical resources, and competitors such as Cerner (CERN) have captured most of the foreign market share using their economies of scale, stagnating Eclipsys Corp's growth both in the U.S and international markets.[9] As of 2007, Eclipsys Corp has obtained only 2.6% market share in the industry.[10]
Eclipsys Corp's primary customers are hospitals, drug manufacturers, and other large medical institutions.[1] Due to the 2008 and 2009 financial crisis, these institutions are forced to reduce immediate spending and maintain paper record databases despite the long-term savings from the adoption of IT-based healthcare. 94% of the hospitals in the United States have cut back on IT spending, while 74% of them have deferred healthcare IT spending to the future.[11] Eclipsys Corp had a decrease in growth from 11.7% in 2007 to 8.0% in 2008.[4] Citing the uncertain economic outlook and the increasingly tight hospital budgets, analysts from Caris & Company have downgraded Eclipsys Corp to an average performer in April, 2009. [12]
Corporate OverviewEclipsys Corp. primarily operates in the United States with its management headquarters located in Atlanta, Georgia.[1] The company provides software services to help medical institutions manage patients and finances. Eclipsys also offers HIT services to blood banks, medical libraries, laboratories, government agencies, drug manufacturers, and most institutions in the healthcare industry.[1] As of 2009, the company provides 28 different IT-based services to large healthcare institutions.[13]
Eclipsys Corp, along with most of the healthcare information services industry, is considered a rapidly growing and changing company.[15] Thus, institutional investors buy company stock in aggregate in an attempt to profit from share price increases associated with rapid growth. More than 95% of Eclipsys stocks are owned by institutional investors.[16] Therefore, Eclipsys Corp. is funded well by capital investors such as Tremblant Capital, a hedge fund that recently reported wishing to hold 6.01% of all shares outstanding[17]
| Select Financial Metrics(thousands) | 2006 | 2007 | 2008 |
| ECLP Revenue[18] | $427,542 | $477,533 | $515,762 |
| ECLP U.S & Canada revenue[18] | $425,128 | $476,235 | $510,650 |
| ECLP International Revenue[18] | $2,414 | $1,298 | $5,112 |
Since the end of 2007, Eclipsys has attempted to expand out of the saturated U.S markets. While the company grew international revenues by 293% since 2007, competing companies such as Cerner Corp. have grown as fast as 1000% in the same period.[18] [19] The Healthcare Information Services industry is aggressively competitive, with many companies' products offering similar benefits at similar prices. Since Eclipsys Corp. is a company with smaller resources than most of its competition, it faces the risk of being crowded out by its competition in consumer segments that are not already well established clients.[20]
Net income has increased a 141% since 2007[14]. While this increase maybe slightly exaggerated due to various small selling and buying of company divisions, the majority of this increase comes from planned investments and contract revenue.[21]
Business SegmentsThe company is officially listed as operating only in one segment, the Healthcare Information Services. However, the company has four distinct sources of revenue. [21]
Key Trends and Forces
Recession has Hurt IT-based HealthcareThe 2008 and 2009 financial crises have adversely affected the availability of resources for hospitals and health institutions.[23] The National Alliance for Health Information Technology reported that 94% of hospitals in the United States have cut back on spending.[11] The financial crisis is also making health institutions prefer software subscription and pay-as-you-go plans instead of the traditional software licensing sales.[24] Since periodic revenue from traditional licensing arrangements carry high margin and contribute significantly to profitability, the health IT sector's profits have seen little growth.
Institutional Investors are moving to Healthcare as a safe growth investmentEven during severe recessions, healthcare tends to perform above market. In the last 45 years, healthcare and healthcare IT have had a minimum growth rate of 5% a year.[25] Thus, institutional investors such as hedge funds and mutual funds are buying healthcare stocks.[26]. For example, during the 2009 financial crisis in April of 2009, a hedge fund named Tremblant Capital indicated it wished to acquire a 6.01% ownership stake in Eclipsys. Tremblant's portfolio previously had a negligible amount of healthcare stocks, and this reallocation is consistent with a trend toward safety in healthcare companies among institutional investors. [27]
Long-Term Movement Towards Digitizing HealthcareAs of 2009, 96.10% of Eclipsys Corp's revenue comes from the fast-growing sector of IT-based healthcare management.[4] Since 2005, there has been an 18.4% increase in hospitals using digital healthcare services and digital patient records.[5] HIMMS, a market research unit, reports that in 2008, hospitals using IT services increased by up to 10%.[5] With 1620 out of the roughly 5700 hospitals using HIT, HIMMS analysts report that the U.S hospital IT market is nearly $33 billion in the US.[28] Similarly, Credit Suisse analysts estimate that $30 billion dollars of opportunity exist globally for healthcare information technology services.[29] They also report that although the 2008 and 2009 financial crisis slowed spending on IT in the short term, the migration to IT-based healthcare is inevitable.[5] The emergence of the electronic medical record has helped hospitals manage data efficiently. Whereas transportation and human error were important factors in paper healthcare systems, digital systems are instant and accessible without error. Hospitals, insurance agents, and employers use IT services to ensure smooth performance, ease of operation, proper patient care, and financial flexibility. While the adoption of IT services to manage health institutions has been slow, there is increasing demand for permanent IT-based healthcare systems. [28] Eclipsys Corp and competitors that offer health information services have the opportunity to provide their services to health institutions in the long term.[30]
CompetitionEclipsys Corp's direct competitors include:
| Name | 2008 Operating Revenue (in millions) [39] | 2008 Net Income (in millions) [39] | 2008 Research & Development (in millions) [39] | 2008 Cost of Sales (in millions) [39] | 2007 Market Share[10][38] |
| McKesson (MCK) | $101,703 | $990 | $347 | $96,323 | 13.50% |
| Cerner (CERN) | $1,676 | $291.36 | $270.58 | $197.15 | 8.50% |
| Eclipsys (ECLP) | $515.76 | $99.51 | $62.29 | $278.36 | 2.60% |
| Allscripts Healthcare Solutions (MDRX) | $312.6 | $12.4 | $0.00 | $157.4 | 1.60% |
| TriZetto Group (TZIX) | $451.8 | $28.23 | $70.6 | $193.80 | 1.90% |
| Rest | N/A | N/A | N/A | N/A | 71.4% |
References



| ||||||
